Medscape Medical NewsAll articles

Deep Learning Image Reconstruction

GE Medical Systems, LLC. • Radiology • 04/12/2019

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

GE's Deep Learning Image Reconstruction is a computed tomography image processing technology utilizing a trained Deep Neural Network to generate "TrueFidelityTM CT Images," designed to combine the visual appeal of traditional FBP with the performance benefits of advanced iterative reconstruction. Non-clinical testing and a clinical reader study demonstrated its capability to maintain image quality metrics such as noise reduction, low contrast detectability, and spatial resolution comparable to its predicate, ASiR-V.

Summary

GE Medical Systems' Deep Learning Image Reconstruction is an advanced option for computed tomography (CT) systems, engineered to produce cross-sectional images of the head, whole body, cardiac, and vascular regions for all patient ages. This technology employs a dedicated Deep Neural Network (DNN), specifically trained on GE's Revolution CT family of systems and integrated into the scanner's raw data-based image reconstruction pipeline to generate images marketed as "TrueFidelityTM CT Images." The scientific basis of this method is to leverage deep learning to emulate the image appearance of traditional Filtered Back Projection (FBP) images, while preserving the performance metrics of its predicate device, ASiR-V, such as image noise levels, low contrast detectability, high-contrast spatial resolution, and streak artifact suppression. The system provides users with selectable reconstruction strengths (Low, Medium, High) to tailor image characteristics to specific clinical requirements and preferences, with reconstruction times designed to support normal CT throughput. To validate its performance, the Deep Learning Image Reconstruction system underwent comprehensive non-clinical and clinical evaluations. Engineering bench tests compared its output directly against ASiR-V using identical raw datasets, assessing metrics like Low Contrast Detectability (LCD), image noise (pixel standard deviation), high-contrast spatial resolution (MTF), streak artifact suppression, Noise Power Spectrum (NPS), CT number accuracy, and uniformity. These tests demonstrated that the new system maintains performance comparable to ASiR-V. Furthermore, a clinical reader study involving 60 retrospective cases was conducted, with images evaluated by nine board-certified radiologists. This study involved assessments of overall image quality using a Likert scale and direct comparisons of images reconstructed with both methods, focusing on image noise texture, sharpness, and noise texture homogeneity. The results supported the system's performance claims, confirming that the "TrueFidelityTM CT Images" are of diagnostic quality, including for the detection of low contrast and small lesions.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Deep LearningImage ReconstructionComputed Tomography (CT)Deep Neural Network (DNN)TrueFidelityTM CT ImagesASiR-VLow Contrast DetectabilityImage NoiseSpatial ResolutionClinical Reader Study

Device Metadata

Submission Number
K183202
Company
GE Medical Systems, LLC.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Generation
AI Subclass
image enhancement

Relevant Clinical Questions

  • Q1. How does the training dataset for the Deep Neural Network (DNN) in the Deep Learning Image Reconstruction influence its performance across diverse patient populations, pathologies, and varying anatomical regions not explicitly detailed in the summary?; What are the specific quantitative differences in image noise (pixel standard deviation), low contrast detectability, and spatial resolution between the "Low," "Medium," and "High" strength settings of the Deep Learning Image Reconstruction?; How does the "image appearance similar to traditional FBP images" objectively compare to actual FBP images in terms of noise texture and subtle artifact presentation, beyond the comparison to ASiR-V, particularly in challenging diagnostic scenarios?; What were the specific criteria for selecting the 60 retrospective clinical cases for the reader study, and how did the system perform on particularly challenging cases, such as those involving significant metal artifacts, motion artifacts, or morbidly obese patients?; Are there any known limitations or specific clinical scenarios where Deep Learning Image Reconstruction might underperform compared to ASiR-V or traditional FBP, particularly regarding the preservation of very subtle, low-amplitude signals or unique artifact patterns?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(training data, deep learning, neural network, algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(network)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Deep Learning Image Reconstruction - GE Medical Systems, LLC. | ESL FDA AI Device Intelligence